176 related articles for article (PubMed ID: 37395053)
1. Application of cell membrane-functionalized biomimetic nanoparticles in the treatment of glioma.
Zhang G; Yao M; Ma S; Zhang K; Wang Y; Wang Z; Liang J; Dai S; Jin R; Guan F
J Mater Chem B; 2023 Aug; 11(30):7055-7068. PubMed ID: 37395053
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early-Stage Glioma.
Chi S; Zhang L; Cheng H; Chang Y; Zhao Y; Wang X; Liu Z
Angew Chem Int Ed Engl; 2023 Jul; 62(29):e202304419. PubMed ID: 37199033
[TBL] [Abstract][Full Text] [Related]
3. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporally sequential delivery of biomimetic liposomes potentiates glioma chemotherapy.
Zhou M; Wu Y; Sun M; Qin Y; Zhao J; Qiu Z; Li C; Zhang Y; Xiong Y; Shen Y; Zou Z; Tu J; Shen W; Sun C
J Control Release; 2024 Jan; 365():876-888. PubMed ID: 38030082
[TBL] [Abstract][Full Text] [Related]
5. Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression.
Zhu S; Sun F; Zhao P; Liang G; Sun X; Zeng L; Huang Y
Int J Pharm; 2022 May; 619():121709. PubMed ID: 35364220
[TBL] [Abstract][Full Text] [Related]
6. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
[TBL] [Abstract][Full Text] [Related]
7. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
Tian X; Shi A; Wu J
Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
9. Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease.
Zhong X; Na Y; Yin S; Yan C; Gu J; Zhang N; Geng F
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903581
[TBL] [Abstract][Full Text] [Related]
10. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
[TBL] [Abstract][Full Text] [Related]
11. A Biomimetic Drug Delivery System by Integrating Grapefruit Extracellular Vesicles and Doxorubicin-Loaded Heparin-Based Nanoparticles for Glioma Therapy.
Niu W; Xiao Q; Wang X; Zhu J; Li J; Liang X; Peng Y; Wu C; Lu R; Pan Y; Luo J; Zhong X; He H; Rong Z; Fan JB; Wang Y
Nano Lett; 2021 Feb; 21(3):1484-1492. PubMed ID: 33475372
[TBL] [Abstract][Full Text] [Related]
12. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery.
Hao W; Cui Y; Fan Y; Chen M; Yang G; Wang Y; Yang M; Li Z; Gong W; Yang Y; Gao C
J Nanobiotechnology; 2021 Nov; 19(1):378. PubMed ID: 34801032
[TBL] [Abstract][Full Text] [Related]
13. Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.
Wu Y; Qian Y; Peng W; Qi X
PeerJ; 2023; 11():e15571. PubMed ID: 37426416
[TBL] [Abstract][Full Text] [Related]
14. Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles.
Jia Y; Wang X; Hu D; Wang P; Liu Q; Zhang X; Jiang J; Liu X; Sheng Z; Liu B; Zheng H
ACS Nano; 2019 Jan; 13(1):386-398. PubMed ID: 30576599
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic Nanocomposites for Glioma Imaging and Therapy.
Chi S; Wang C; Liu Z
Chemistry; 2024 Jun; 30(31):e202304338. PubMed ID: 38538540
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma.
Ma X; Kuang L; Yin Y; Tang L; Zhang Y; Fan Q; Wang B; Dong Z; Wang W; Yin T; Wang Y
ACS Nano; 2023 Feb; 17(3):2341-2355. PubMed ID: 36688797
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma.
Wu L; Li Q; Deng J; Shen J; Xu W; Yang W; Chen B; Du Y; Zhang W; Ge F; Lei S; Li K; Wang Z
Int J Nanomedicine; 2021; 16():8433-8446. PubMed ID: 35002237
[TBL] [Abstract][Full Text] [Related]
18. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges.
Wu H; Zhang T; Li N; Gao J
J Control Release; 2023 Aug; 360():169-184. PubMed ID: 37343724
[TBL] [Abstract][Full Text] [Related]
19. Natural polymeric nanocarriers in malignant glioma drug delivery and targeting.
Gao Y; Wang R; Zhao L; Liu A
J Drug Target; 2021 Nov; 29(9):960-973. PubMed ID: 33745392
[TBL] [Abstract][Full Text] [Related]
20. Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes.
Liao J; Gong L; Xu Q; Wang J; Yang Y; Zhang S; Dong J; Lin K; Liang Z; Sun Y; Mu Y; Chen Z; Lu Y; Zhang Q; Lin Z
Adv Mater; 2024 Jun; 36(26):e2402445. PubMed ID: 38583077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
